Few studies have demonstrated that innate lymphocytes play a major role in preventing spontaneous tumor formation. We evaluated the development of spontaneous tumors in mice lacking β-2 microglobulin (β2m; and thus MHC class I, CD1d, and CD16) and/or perforin, since these tumor cells would be expected to activate innate effector cells. Approximately half the cohort of perforin gene-targeted mice succumbed to spontaneous disseminated B cell lymphomas and in mice that also lacked β2m, the lymphomas developed earlier (by more than 100 d) and with greater incidence (84%). B cell lymphomas from perforin/β2m gene-targeted mice effectively primed cell-mediated cytotoxicity and perforin, but not IFN-γ, IL-12, or IL-18, was absolutely essential for tumor rejection. Activated NK1.1+ and γδTCR+ T cells were abundant at the tumor site, and transplanted tumors were strongly rejected by either, or both, of these cell types. Blockade of a number of different known costimulatory pathways failed to prevent tumor rejection. These results reflect a critical role for NK cells and γδTCR+ T cells in innate immune surveillance of B cell lymphomas, mediated by as yet undetermined pathway(s) of tumor recognition.
Skip Nav Destination
Article navigation
15 March 2004
Article Contents
Brief Definitive Report|
March 08 2004
Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells
Shayna E.A. Street,
Shayna E.A. Street
1Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre (Peter Mac), 8006, Victoria, Australia
Search for other works by this author on:
Yoshihiro Hayakawa,
Yoshihiro Hayakawa
1Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre (Peter Mac), 8006, Victoria, Australia
Search for other works by this author on:
Yifan Zhan,
Yifan Zhan
2The Walter and Eliza Hall Institute of Medical Research, 3050, Victoria, Australia
Search for other works by this author on:
Andrew M. Lew,
Andrew M. Lew
2The Walter and Eliza Hall Institute of Medical Research, 3050, Victoria, Australia
Search for other works by this author on:
Duncan MacGregor,
Duncan MacGregor
3The Department of Anatomical Pathology, The Austin and Repatriation Medical Centre, 3084, Heidelberg, Australia
Search for other works by this author on:
Amanda M. Jamieson,
Amanda M. Jamieson
4Department of Molecular and Cell Biology and Cancer Research Laboratory, University of California, Berkeley, Berkeley, CA 94720
Search for other works by this author on:
Andreas Diefenbach,
Andreas Diefenbach
5Skirball Institute of Biomolecular Medicine, New York University, New York, NY 10016
Search for other works by this author on:
Hideo Yagita,
Hideo Yagita
6Department of Immunology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, 113-8421, Japan
Search for other works by this author on:
Dale I. Godfrey,
Dale I. Godfrey
7Department of Microbiology and Immunology, University of Melbourne, Parkville, 3052, Victoria, Australia
Search for other works by this author on:
Mark J. Smyth
Mark J. Smyth
1Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre (Peter Mac), 8006, Victoria, Australia
Search for other works by this author on:
Shayna E.A. Street
1Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre (Peter Mac), 8006, Victoria, Australia
Yoshihiro Hayakawa
1Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre (Peter Mac), 8006, Victoria, Australia
Yifan Zhan
2The Walter and Eliza Hall Institute of Medical Research, 3050, Victoria, Australia
Andrew M. Lew
2The Walter and Eliza Hall Institute of Medical Research, 3050, Victoria, Australia
Duncan MacGregor
3The Department of Anatomical Pathology, The Austin and Repatriation Medical Centre, 3084, Heidelberg, Australia
Amanda M. Jamieson
4Department of Molecular and Cell Biology and Cancer Research Laboratory, University of California, Berkeley, Berkeley, CA 94720
Andreas Diefenbach
5Skirball Institute of Biomolecular Medicine, New York University, New York, NY 10016
Hideo Yagita
6Department of Immunology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, 113-8421, Japan
Dale I. Godfrey
7Department of Microbiology and Immunology, University of Melbourne, Parkville, 3052, Victoria, Australia
Mark J. Smyth
1Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre (Peter Mac), 8006, Victoria, Australia
Address correspondence to M.J. Smyth, Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre (Peter Mac), Locked Bag 1, A'Beckett St, 8006, Victoria, Australia. Phone: 61-3-9656-3728; Fax: 61-3-9656-1411; email: [email protected]
The online version of this article contains supplemental material.
Received:
November 17 2003
Accepted:
February 03 2004
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2004
J Exp Med (2004) 199 (6): 879–884.
Article history
Received:
November 17 2003
Accepted:
February 03 2004
Citation
Shayna E.A. Street, Yoshihiro Hayakawa, Yifan Zhan, Andrew M. Lew, Duncan MacGregor, Amanda M. Jamieson, Andreas Diefenbach, Hideo Yagita, Dale I. Godfrey, Mark J. Smyth; Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells . J Exp Med 15 March 2004; 199 (6): 879–884. doi: https://doi.org/10.1084/jem.20031981
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement